Förening av forskningskvalitet. Endast för laboratoriebruk. Inte avsedd för användning, intag eller injektion på människa eller djur. Inga medicinska påståenden görs eller antyds.
Adipotide
Gratis frakt på beställningar över €200
- Om en produkt inte motsvarar specifikationen i sitt publicerade COA, kontakta oss med ditt batchnummer: vi utreder mot lotens rapport och ersätter varje produkt som inte klarar den, utan kostnad för dig.
- Kontakta oss inom 48 timmar efter leverans med foton av ytterkartongen, innerförpackningen och eventuella berörda vialer med läsbara etiketter. Bekräftade transportskador ersätts utan kostnad för dig.
3–7 dagar till de flesta EU-länder · 10–14 dagar till Norden och de baltiska staterna
Standardfrakt inom EU från 4,99 € (RO) · centrala EU-länder (GLS) 17,99 € · Norden och de baltiska staterna 12,99 €–15,99 € · Skickas inom 1–2 arbetsdagar · Fri frakt över 200,00 € · inga tullhandlingar (EU) · via nätverket av transportörer inom EU
200,00 € kvar till fri frakt över 200,00 €. Under det beloppet kostar standardfrakt inom EU 17,99 € (GLS, de flesta EU-länder).
Så fungerar Paysera och SEPA
- Betala: skicka en manuell SEPA-överföring med det IBAN vi mejlar dig, eller, om kassan erbjuder det för din adress, godkänn en SEPA-överföring i din egen bank via Payseras hostade sida.
- Vi bekräftar: Paysera meddelar oss direkt, eller så matchar vi en manuell överföring när den kommer in (vanligtvis inom 1 arbetsdag).
- Vi skickar: bekräftade beställningar skickas vanligtvis inom 1-2 arbetsdagar.
Kortbetalningar erbjuds för närvarande inte. Det finns ingen kortbetalningstjänst i den här kassan.
Research-grade Adipotide. Class-level specification ≥98%. Lyophilized powder in sealed glass vial. For laboratory research use only. Not for human consumption.
Viktig information
Denna produkt är endast avsedd för laboratorie- och forskningsanvändning. Inte för användning på människor eller i veterinärmedicin. Genom att köpa bekräftar du att denna produkt uteslutande kommer att användas för in vitro-forskningsändamål.
På grund av rättsliga och regulatoriska krav kan den här produkten inte skickas till: Italien, Kroatien, Litauen och Slovenien.
Rekonstituering krävs
Denna peptid skickas lyofiliserad (torrt pulver) och kräver bakteriostatiskt vatten för rekonstituering före användning. BAC-vatten säljs separat.
När den här produkten kanske inte passar din forskning
- ⚠Om din forskning kräver material i GMP-kvalitet för kliniska tillämpningar – peptider i forskningskvalitet är inte avsedda för klinisk användning.
- ⚠Om ditt laboratorium saknar lämplig kallförvaring (-20°C-frys) – den här peptidens stabilitet kan försämras vid högre temperaturer.
- ⚠Om ditt studieprotokoll kräver FDA-godkända referensstandarder – kontakta USP eller en leverantör av certifierat referensmaterial.
Publicerade laboratorierapporter finns för utvalda partier. Kontrollera resultatet och den angivna metoden i varje rapport. Endast för forskningsändamål.
Janoshik-rapport publiceras när den blir tillgänglig
Expediering inom 1–2 arbetsdagar, leverans från 4,99 € i Rumänien, från 12,99 € i resten av Europa
Registrerad specifikation på klassnivå; oberoende Janoshik-rapport för utvalda partier
Om Adipotide
For research purposes only. Not for human or veterinary use.
Overview
Adipotide (also written as FTPP, or by its sequence CKGGRAKDC-GG-D(KLAKLAK)2) is a proapoptotic peptidomimetic built for vascular targeting of white adipose tissue. Two functional halves are joined in a single molecule: a homing peptide, CKGGRAKDC, that binds prohibitin displayed on the endothelium of blood vessels feeding white fat, and a proapoptotic domain, D(KLAKLAK)2, that disrupts mitochondrial membranes once it is internalised. The homing sequence was originally isolated through in vivo phage-display screening for peptides that localise to white adipose tissue vasculature, which is what gives the conjugate its tissue selectivity in research models.
The molecule was characterised by researchers at the University of Texas MD Anderson Cancer Center. It is frequently discussed as a conceptual parallel to antibody-drug conjugates: the cytotoxic payload is only delivered where the targeting element has bound, so activity is concentrated at the intended vascular bed rather than distributed systemically. CertaPeptides is a reseller and supplies Adipotide as a research reagent; we do not manufacture, formulate, or select the salt form of this compound.
Research Areas
Published literature has investigated Adipotide primarily as a tool for studying adipose-tissue vascular biology and the metabolic consequences of ablating fat-feeding vasculature. In the foundational mouse work, targeted ablation of adipose vasculature was used to study adipose-tissue remodelling and established prohibitin on adipose endothelium as an addressable target (Kolonin et al., 2004). A later non-human primate study examined tissue selectivity, metabolic parameters and renal markers (Barnhart et al., 2011). These two datasets remain the most cited reference points for researchers modelling vascular-targeting approaches to adipose tissue. Typical research questions include how selective prohibitin targeting is across different vascular beds, how model organisms respond to adipose vascular ablation, and how the conjugate format governs where apoptosis is triggered.
Specifications
| Compound | Adipotide / CKGGRAKDC-GG-D(KLAKLAK)2 |
|---|---|
| Purity | ≥98% (class-level specification) |
| Format | Lyophilized powder |
| Reconstitution | Sterile water or PBS |
| Storage | −20°C lyophilized; 2–8°C after reconstitution, use within 14 days |
Quality & Verification
The class-level specification on record is ≥98%. No independent report is on record for this product yet; independent reports on selected lots are searchable by batch or report code at certapeptides.com/verify. We make no in-house testing claim and do not test every batch. EU-based handling under CERTALAB S.R.L.
Frequently Asked Questions
What is adipotide used for in research?
In the published literature, adipotide is used as a research tool to study vascular targeting of white adipose tissue. It combines a peptide that homes to prohibitin on adipose-feeding blood vessels with a proapoptotic domain, letting researchers investigate what happens in model systems when that specific vasculature is ablated. It is supplied for laboratory research only and is not for human or veterinary use.
How does adipotide target fat tissue specifically?
The CKGGRAKDC portion of the molecule was identified through in vivo phage-display screening for peptides that home to white adipose tissue vasculature. Its target, prohibitin, is displayed on the endothelium of fat-feeding vessels. Once the homing peptide binds, the D(KLAKLAK)2 domain is internalised and disrupts mitochondrial membranes, so activity is concentrated at the targeted vascular bed rather than distributed broadly.
What did the primate study report?
Barnhart and colleagues (2011, Science Translational Medicine) studied adipotide in rhesus monkeys, reporting on tissue selectivity, metabolic parameters and renal markers in the model animals. This primate dataset is the most advanced preclinical reference point cited for the compound.
What is a proapoptotic peptide-drug conjugate?
It is a molecule that pairs a targeting peptide with a cell-death-inducing payload, conceptually similar to an antibody-drug conjugate. In adipotide, the targeting peptide delivers the D(KLAKLAK)2 domain to adipose endothelial cells; the payload only acts where the targeting element has bound, which is the source of the conjugate's selectivity in research models.
How should adipotide be stored?
Store the lyophilized powder at −20°C, protected from light. After reconstitution with sterile water or PBS, keep refrigerated at 2–8°C and use within roughly 14 days. Handle in line with standard peptide-handling and institutional biosafety guidelines.
For research purposes only. Not for human consumption.
Specifikationssammanfattning
Om Adipotide
For research purposes only. Not for human or veterinary use.
Overview
Adipotide (also written as FTPP, or by its sequence CKGGRAKDC-GG-D(KLAKLAK)2) is a proapoptotic peptidomimetic built for vascular targeting of white adipose tissue. Two functional halves are joined in a single molecule: a homing peptide, CKGGRAKDC, that binds prohibitin displayed on the endothelium of blood vessels feeding white fat, and a proapoptotic domain, D(KLAKLAK)2, that disrupts mitochondrial membranes once it is internalised. The homing sequence was originally isolated through in vivo phage-display screening for peptides that localise to white adipose tissue vasculature, which is what gives the conjugate its tissue selectivity in research models.
The molecule was characterised by researchers at the University of Texas MD Anderson Cancer Center. It is frequently discussed as a conceptual parallel to antibody-drug conjugates: the cytotoxic payload is only delivered where the targeting element has bound, so activity is concentrated at the intended vascular bed rather than distributed systemically. CertaPeptides is a reseller and supplies Adipotide as a research reagent; we do not manufacture, formulate, or select the salt form of this compound.
Research Areas
Published literature has investigated Adipotide primarily as a tool for studying adipose-tissue vascular biology and the metabolic consequences of ablating fat-feeding vasculature. In the foundational mouse work, targeted ablation of adipose vasculature was used to study adipose-tissue remodelling and established prohibitin on adipose endothelium as an addressable target (Kolonin et al., 2004). A later non-human primate study examined tissue selectivity, metabolic parameters and renal markers (Barnhart et al., 2011). These two datasets remain the most cited reference points for researchers modelling vascular-targeting approaches to adipose tissue. Typical research questions include how selective prohibitin targeting is across different vascular beds, how model organisms respond to adipose vascular ablation, and how the conjugate format governs where apoptosis is triggered.
Specifications
| Compound | Adipotide / CKGGRAKDC-GG-D(KLAKLAK)2 |
|---|---|
| Purity | ≥98% (class-level specification) |
| Format | Lyophilized powder |
| Reconstitution | Sterile water or PBS |
| Storage | −20°C lyophilized; 2–8°C after reconstitution, use within 14 days |
Quality & Verification
The class-level specification on record is ≥98%. No independent report is on record for this product yet; independent reports on selected lots are searchable by batch or report code at certapeptides.com/verify. We make no in-house testing claim and do not test every batch. EU-based handling under CERTALAB S.R.L.
Frequently Asked Questions
What is adipotide used for in research?
In the published literature, adipotide is used as a research tool to study vascular targeting of white adipose tissue. It combines a peptide that homes to prohibitin on adipose-feeding blood vessels with a proapoptotic domain, letting researchers investigate what happens in model systems when that specific vasculature is ablated. It is supplied for laboratory research only and is not for human or veterinary use.
How does adipotide target fat tissue specifically?
The CKGGRAKDC portion of the molecule was identified through in vivo phage-display screening for peptides that home to white adipose tissue vasculature. Its target, prohibitin, is displayed on the endothelium of fat-feeding vessels. Once the homing peptide binds, the D(KLAKLAK)2 domain is internalised and disrupts mitochondrial membranes, so activity is concentrated at the targeted vascular bed rather than distributed broadly.
What did the primate study report?
Barnhart and colleagues (2011, Science Translational Medicine) studied adipotide in rhesus monkeys, reporting on tissue selectivity, metabolic parameters and renal markers in the model animals. This primate dataset is the most advanced preclinical reference point cited for the compound.
What is a proapoptotic peptide-drug conjugate?
It is a molecule that pairs a targeting peptide with a cell-death-inducing payload, conceptually similar to an antibody-drug conjugate. In adipotide, the targeting peptide delivers the D(KLAKLAK)2 domain to adipose endothelial cells; the payload only acts where the targeting element has bound, which is the source of the conjugate's selectivity in research models.
How should adipotide be stored?
Store the lyophilized powder at −20°C, protected from light. After reconstitution with sterile water or PBS, keep refrigerated at 2–8°C and use within roughly 14 days. Handle in line with standard peptide-handling and institutional biosafety guidelines.
For research purposes only. Not for human consumption.
Relaterad forskningsläsning
Objektiva jämförelser och forskningsguider om denna förening. Referensmaterial endast för forskningsbruk.
Forskarnas förtroende
Varför forskare väljer CertaPeptides
Vem testar egentligen detta?
Utvalda partier verifieras oberoende av Janoshik Analytical (Tjeckien) och publiceras på Janoshiks offentliga portal. Övriga partier levereras med leverantörens partispecifikation. Se /coa för den publicerade väggen.
Visa COA:er →Tänk om jag får fel parti?
Etiketten på varje vial bär en kod. Slå upp den på vår verifieringssida: där ser du vad CertaPeptides publicerar för koden och, för ett indraget parti, att partiet har dragits in och varför. Är ditt parti indraget, eller ger koden på din etikett ingen träff, skicka då den koden till oss via e-post.
Visa COA:er →Varifrån skickas det?
Rumänien (EU). Vi är CERTALAB SRL, CUI 54169956, momsregistrerade. Sameday för Rumänien, GLS för de flesta EU-destinationer, TCE Worldwide för övriga gränsöverskridande EU- och icke-EU-marknader (Storbritannien, Schweiz). Leverans 1–15 arbetsdagar beroende på destination — exakt tidsfönster visas i kassan.
Fraktinformation →Tänk om det uppstår ett problem?
Du har 14 dagars ångerrätt enligt OUG 34/2014 (rumänsk/EU-konsumentlagstiftning), med möjlighet till eskalering via ANPC och till alternativ tvistlösning (SAL). Kontakta oss på support@certapeptides.com.
Returpolicy →Produktinformation
Denna produkt är endast avsedd för vetenskaplig forskning och utveckling. Det är ett kemiskt ämne som inte får användas som läkemedel, medicin, aktiv substans eller ingrediens i någon produkt avsedd för konsumtion av människor eller djur. Forskare måste hantera denna förening i enlighet med sina institutionella riktlinjer för biosäkerhet. Använd endast i korrekt utrustade laboratoriemiljöer med lämplig personlig skyddsutrustning.
